BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37522494)

  • 1. Impact of blue light on skin pigmentation in patients with melasma.
    Li L; Jiang X; Tu Y; Yang Y; Zhang X; Gu H; He L
    Skin Res Technol; 2023 Jul; 29(7):e13401. PubMed ID: 37522494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.
    Alcantara GP; Esposito ACC; Olivatti TOF; Yoshida MM; Miot HA
    An Bras Dermatol; 2020; 95(6):684-690. PubMed ID: 33010989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visible light photopatch testing of common photocontactants in female filipino adults with and without melasma: a cross-sectional study.
    Verallo-Rowell VM; Pua JM; Bautista D
    J Drugs Dermatol; 2008 Feb; 7(2):149-56. PubMed ID: 18335651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Management of Melasma on Skin Types V and VI Using Light Emitting Diode Treatment.
    Mpofana N; Abrahamse H
    Photomed Laser Surg; 2018 Oct; 36(10):522-529. PubMed ID: 30227084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigmentation effects of blue light irradiation on skin and how to protect against them.
    Campiche R; Curpen SJ; Lutchmanen-Kolanthan V; Gougeon S; Cherel M; Laurent G; Gempeler M; Schuetz R
    Int J Cosmet Sci; 2020 Aug; 42(4):399-406. PubMed ID: 32478879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of a novel sunscreen against blue light.
    Francois-Newton V; Kolanthan VL; Mandary MB; Philibert EG; Soobramaney V; Petkar G; Sokeechand BN; Hosenally M; Cavagnino A; Baraibar MA; Ng SP
    Int J Cosmet Sci; 2022 Aug; 44(4):464-476. PubMed ID: 35689421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melasma: How hormones can modulate skin pigmentation.
    Filoni A; Mariano M; Cameli N
    J Cosmet Dermatol; 2019 Apr; 18(2):458-463. PubMed ID: 30779300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese women with melasma exhibit a low minimal erythema dose to both UVA and UVB.
    Wang Z; Lu F; Li X; Guo Y; Li J; He L
    Photodermatol Photoimmunol Photomed; 2022 Jan; 38(1):38-43. PubMed ID: 34171129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Protocol for Long-Term Results With a Multi-Pulse Nd:YAG Laser for Melasma Treatment: A Descriptive Cohort Study.
    Ocampo JCV; Ocampo SV; Vélez NC; Braun M
    J Drugs Dermatol; 2021 Feb; 20(2):150-154. PubMed ID: 33538564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acid as a new therapeutic peeling agent in melasma.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2005 Feb; 31(2):149-54; discussion 154. PubMed ID: 15762205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of melasma in Brazilian patients: a multicenter study.
    Hexsel D; Lacerda DA; Cavalcante AS; Machado Filho CA; Kalil CL; Ayres EL; Azulay-Abulafia L; Weber MB; Serra MS; Lopes NF; Cestari TF
    Int J Dermatol; 2014 Apr; 53(4):440-4. PubMed ID: 23967822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.
    Tamega Ade A; Miot HA; Moço NP; Silva MG; Marques ME; Miot LD
    Int J Cosmet Sci; 2015 Apr; 37(2):222-8. PubMed ID: 25439299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast morphology, growth rate and gene expression in facial melasma.
    Espósito ACC; Brianezi G; Miot LDB; Miot HA
    An Bras Dermatol; 2022; 97(5):575-582. PubMed ID: 35840442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescent fibroblasts in melasma pathophysiology.
    Kim M; Kim SM; Kwon S; Park TJ; Kang HY
    Exp Dermatol; 2019 Jun; 28(6):719-722. PubMed ID: 30575141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 590 nm LED Irradiation Improved Erythema through Inhibiting Angiogenesis of Human Microvascular Endothelial Cells and Ameliorated Pigmentation in Melasma.
    Dai X; Jin S; Xuan Y; Yang Y; Lu X; Wang C; Chen L; Xiang L; Zhang C
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.